content

WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has...

CVS Pharmacy, Inc., a subsidiary of CVS Health Corporation , and Schnucks announced that they have entered into a definitive agreement for CVS Pharmacy...

Invitae Corporation , a leading medical genetics company, announced it has entered into definitive agreements to acquire YouScript, a privately held clinical decision support...

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the Coalition for Epidemic Preparedness Innovations (CEPI) awarded an...

Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced achievement of full patient enrollment in its Phase...

Johnson & Johnson announced that the Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Apple, opened enrollment for the Heartline™ Study. The...

Bellerophon Therapeutics, Inc , a clinical-stage biotherapeutics company, announced the successful completion of its End-of-Phase 2 Meetings with the U.S. FDA for INOpulse for...